DK
Daiki Karigane
Institute of Science Tokyo, Stanford University, Graduate School of Medicine, Keio University, School of Medicine, Keio University
Research areas: Medicine · Hematology · Acute Myeloid Leukemia Research · Hematopoietic Stem Cell Transplantation · Epigenetics and DNA Methylation
0000-0002-4017-5193
Employment
-
Institute of Science Tokyo Associate Professor2024 - Present
-
Stanford University Instructor2022 - 2024
- 2018 - 2022
-
School of Medicine, Keio University2012 - 2017
Education
-
Graduate School of Medicine, Keio University Ph.D.2012 - 2016
-
School of Medicine, Keio University M.D.2002 - 2008
Projects & Funding
Projects & funding information is unavailable.
Publications (54)
- DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Data from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S1 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S2 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S3 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S4 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S5 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S6 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Figures S1-S11 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S1 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S2 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S3 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S4 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S5 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S6 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S7 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S8 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Data from Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML Save
- Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML Save
- Supplementary Figure S1-S8 from Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML Save